Biologic agents or protein-based drugs are increasingly used in dermatology for treatment of psoriasis.
These products have also gained traction in the treatment of other inflammatory skin diseases.
Production of biosimilars is likely to increase in dermatological products market as these drugs have similar active ingredients to biologic medicines and are more cost-effective.Get Sample PDF Illustration Here - https://www.factmr.com/connectus/sample?flag=S_id=2363Based on the regulatory approach of biosimilars, increasing number of biosimilar drugs are set to enter Europe and the US in the coming years.
Moreover, with increasing prevalence of psoriasis in children across the world, manufacturers in dermatological products market are working towards developing effective biologics for children with psoriasis.Dermo-Cosmetic Products Emerging as an Effective Solution for Skin Related ComplaintsThe rise in skin allergies and lifestyle-related skin complaints is resulting in increasing use of dermo-cosmetic products by consumers to treat common skin conditions such as eczema, acne, extreme skin sensitivity, and reactive skin.
Majority of the dermo-cosmetics products are developed on a large scale in Western European countries including Italy, France, and Spain.New dermatological products formulas and developments are also on a rise, for instance, Pierre Fabre has launched sterile cosmetics, industries first sterile skincare line made without preservatives and fragrance.
The company used a limited number of ingredients and offers D.E.F.I.